Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FIGY
Barclays ETN+ FI Enhanced Global High Yield ETN
FIGY
|
+$1.09B |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$984M |
| 3 |
Pfizer
PFE
|
+$895M |
| 4 |
Johnson & Johnson
JNJ
|
+$862M |
| 5 |
American Express
AXP
|
+$773M |
Top Sells
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.04% |
| 2 | Technology | 14.87% |
| 3 | Healthcare | 12.6% |
| 4 | Consumer Staples | 8.81% |
| 5 | Consumer Discretionary | 8.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
COPT Defense Properties
CDP
$4.35B
| $21.3M | 0.06% |
+835,008
| New | +$23M |
|
177
Revvity
RVTY
$12.7B
| $20.8M | 0.05% |
+638,685
| New | +$20.9M |
|
|
CNL
178
DELISTED
CLECO CRP (HOLDING CO)
CNL
| $19.9M | 0.05% |
+427,908
| New | +$20M |
|
179
iShares MSCI EAFE ETF
EFA
$78.5B
| $19.5M | 0.05% |
+340,681
| New | +$20.6M |
|
180
Banco Santander Chile
BSAC
$16.5B
| $18.6M | 0.05% |
+759,370
| New | +$19.5M |
|
|
SGI
181
Somnigroup International
SGI
$14.1B
| $18.1M | 0.05% |
+1,650,540
| New | +$18.8M |
|
182
Teradyne
TER
$57.2B
| $17M | 0.04% |
+967,271
| New | +$16.1M |
|
183
MKS Inc
MKSI
$19.8B
| $16.7M | 0.04% |
+630,999
| New | +$17.1M |
|
|
GHL
184
DELISTED
Greenhill & Co., Inc.
GHL
| $16.4M | 0.04% |
+357,937
| New | +$17.3M |
|
|
SAPE
185
DELISTED
SAPIENT CORP
SAPE
| $15.7M | 0.04% |
+1,205,745
| New | +$14.5M |
|
186
Expedia Group
EXPE
$35.2B
| $15.2M | 0.04% |
+253,130
| New | +$15M |
|
187
Weyerhaeuser
WY
$16.9B
| $15.2M | 0.04% |
+532,837
| New | +$16.1M |
|
188
Kroger
KR
$35.4B
| $15.1M | 0.04% |
+873,670
| New | +$14.9M |
|
189
Mastercard
MA
$510B
| $15M | 0.04% |
+260,250
| New | +$14.5M |
|
190
Ameriprise Financial
AMP
$48.1B
| $14.9M | 0.04% |
+184,488
| New | +$14.3M |
|
191
Cencora
COR
$60.7B
| $14.4M | 0.04% |
+258,089
| New | +$14M |
|
192
Equifax
EFX
$20.7B
| $14M | 0.04% |
+237,543
| New | +$14.3M |
|
193
Toll Brothers
TOL
$14B
| $13.9M | 0.04% |
+427,272
| New | +$14.4M |
|
|
STJ
194
DELISTED
St Jude Medical
STJ
| $13.9M | 0.04% |
+304,013
| New | +$13.2M |
|
195
Omnicom Group
OMC
$21.8B
| $13.7M | 0.04% |
+217,792
| New | +$13.4M |
|
196
T. Rowe Price
TROW
$25.6B
| $13.4M | 0.03% |
+182,894
| New | +$13.7M |
|
197
Zimmer Biomet
ZBH
$18.4B
| $13.3M | 0.03% |
+183,273
| New | +$13.7M |
|
|
AVP
198
DELISTED
Avon Products, Inc.
AVP
| $13.1M | 0.03% |
+624,609
| New | +$14M |
|
|
PCH
199
DELISTED
PotlatchDeltic
PCH
| $13M | 0.03% |
+320,665
| New | +$14.7M |
|
|
SNDK
200
DELISTED
SANDISK CORP
SNDK
| $12.9M | 0.03% |
+211,092
| New | +$12M |
|
Similar funds
Ken Fisher's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Ken Fisher, which disclosed 525 positions worth $38.5B. Its ten largest holdings account for 21% of the portfolio.
Its largest position is Barclays ETN+ FI Enhanced Global High Yield ETN: 11,772,806 shares worth $1.05B.
By sector, the portfolio is most concentrated in Financials at 16% of assets, followed by Technology and Healthcare.
- Ken Fisher's largest Q2 2013 buy was Barclays ETN+ FI Enhanced Global High Yield ETN: 11,772,806 shares worth $1.05B.
- Ken Fisher's ten largest holdings make up 21% of its $38.5B portfolio in Q2 2013.
- Ken Fisher disclosed 525 positions in Q2 2013, its first 13F filing on record.
Based on Fisher Asset Management's 13F filing for Q2 2013, filed 16 Jul 2013.